Evidence map›Paper›PMID 11526468›Full record

ArticleMolecular psychiatry2001

Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls.

N Hiroi, M L Wong, J Licinio, C Park, M Young, P W Gold, G P Chrousos, S R Bornstein

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Effect of CRHR1 and CRHR2 gene polymorphisms and childhood trauma in suicide attempt.Journal of neural transmission (Vienna, Austria : 1996) · 2019
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Family Economic Hardship, Corticotropin-Releasing Hormone Receptor Polymorphisms, and Depressive Symptoms in Rural African-American Youths.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

N HiroiPediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
M L Wong
J Licinio
C Park
M Young
P W Gold
G P Chrousos
S R Bornstein
National Institutes of Health · USUniversity of California, Los Angeles · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USHeinrich Heine University Düsseldorf · DENational Institute of Mental Health · US

Funding

UCLA CENTER FOR DIETARY SUPPLEMENTS RESEARCH: BOTANICALSP50AT000151 · NCCIH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HEBER, DAVID NONE · 1999 to 2004
$6.5M
UCLA PHARMACOGENETICS &PHARMACOGENOMICS RESEARCH GROUPU01GM061394 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LICINIO, JULIO · 2000 to 2005
$4.7M
ENDOCRINE EFFECTS OF HUMAN LEPTIN REPLACEMENTR01DK058851 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LICINIO, JULIO · 2001 to 2005
$1.8M
UCLA GRADUATE TRAINING PROGRAM IN TRANSITIONAL INVESTIGAK30HL004526 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LICINIO, JULIO · 2000 to 2004
$995k
THE NEUROBIOLOGY OF UNIPOLAR DEPRESSIONZ01MH002659 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI GOLD, PHILIP W · 1993 to 2008
$940k
NCCIH NIH HHS P50 AT00151NHLBI NIH HHS K30 HL04526NIDDK NIH HHS R01 DK58851NIGMS NIH HHS U01 GM61394
6 · The paper itself

Abstract

Corticotropin-releasing hormone (CRH) is a key neuroendocrine factor implementing endocrine, immune and behavioral responses to stress. CRH exerts its action through two major receptors, CRH-R1 and CRH-R2. Recently novel non-peptidic antagonists directed against CRH-R1 or CRH-R2 have been proposed as promising agents in the treatment of depression, anxiety and eating disorder. However, so far the CRH-receptor system has not been widely studied in humans. Therefore, we employed quantitative TaqMan PCR to analyze the expression and distribution of both CRH-R1 and CRH-R2 in human brain tissue and peripheral organs. Furthermore the expression of CRH receptors was analyzed for the first time in pituitaries of suicide victims by in situ hybridization and quantitative PCR. Our data demonstrated a different expression pattern in humans as compared to rodents. Both CRH-R1 and CRH-R2 were expressed in high amounts in the brain with the strongest expression in the pituitary. As described in rodents, however the CRH-R1 in human was the predominant receptor in the brain (82.7 +/- 11.0%), whilst CRH-R2 was the predominant receptor in peripheral organs (77.0 +/- 15.8%). There was a shift in the ratio of CRH-R1/R2 in the pituitaries of suicide victims. In conclusion, both CRH-R1 and CRH-R2 are widely expressed in human tissues with a distribution substantially different from rodents. Strong expression of both CRH-R1 and CRH-R2 in human pituitaries suggests that particularly under stress, activation of the HPA axis can be maintained through both receptors.

Indexed as

SuicideTranscription, GeneticAdolescentAdultAgedBrainCRF Receptor, Type 1HumansIn Situ HybridizationMiddle AgedOrgan SpecificityPituitary GlandPolymerase Chain ReactionReceptors, Corticotropin-Releasing HormoneReference ValuesRNA, MessengerCRF Receptor, Type 1CRF receptor type 2Receptors, Corticotropin-Releasing HormoneRNA, Messenger

Identifiers

PMID11526468
OpenAlexW2016055236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.